Preweaning sensorimotor deficits and adolescent hypersociability in Grin1 knockdown mice

Developmental Neuroscience

Volumn 34, Issue 2-3, 2012, Pages 159-173

  Moy, Sheryl S ^a   Nikolova, Viktoriya D ^a   Riddick, Natallia V ^a   Baker, Lorinda K ^a   Koller, Beverly H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Hyperactivity; Impulsive behavior; NMDA receptor; Postnatal period; Prepulse inhibition; Schizophrenia; Social approach; Startle

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID;

ADOLESCENCE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTISOCIAL BEHAVIOR; ARTICLE; AUDITORY RESPONSE; AUDITORY STIMULATION; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GENE; GENE FUNCTION; HYPERSOCIABILITY; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHIZOPHRENIA; SENSORIMOTOR NEUROPATHY; SIGNAL TRANSDUCTION; SNIFFING; SOCIAL BEHAVIOR; STARTLE REFLEX;

AGE FACTORS; ANIMALS; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SENSORY GATING; SEX FACTORS; SOCIAL BEHAVIOR; STARTLE REACTION;

EID: 84866291592     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000337984     Document Type: Article

References (71)

1. Coyle JT: Glutamate and schizophrenia: Beyond the dopamine hypothesis. Cell Mol Neurobiol 2006; 26: 365-384.
2. Jentsch JD, Roth RH: The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999; 20: 201-225.
3. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B: Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 1980; 20: 379-382.
4. Moghaddam B: Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 859-870.
5. Olney JW, Farber NB: Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995; 52: 998-1007.
6. Marshall BE, Longnecker DE: General anesthetics; in Gilman AG, Rall TW, Nies AS, Taylor P (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York, Pergamon Press, 1990.
7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-IV TR (Text Revision). Arlington, American Psychiatric Association, 2000. 8 Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, Snouwaert JN, Koller BH: Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 2004; 153: 507-519.
8. Halene TB, Ehrlichman RS, Liang Y, Christian EP, Jonak GJ, Gur TL, Blendy JA, Dow HC, Brodkin ES, Schneider F, Gur RC, Siegel SJ: Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav 2009; 8: 661-675.
9. Mohn AR, Gainetdinov RR, Caron MG, Koller BH: Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999; 98: 427-436.
10. Ramsey AJ: NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia. Prog Brain Res 2009; 179: 51-58.
11. Fradley RL, O'Meara GF, Newman RJ, Andrieux A, Job D, Reynolds DS: STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res 2005; 163: 257-264.
12. Moy SS, Perez A, Koller BH, Duncan GE: Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function. Brain Res 2006; 1089: 186-194.
13. Moy SS, Nadler JJ, Poe MD, Nonneman RJ, Young NB, Koller BH, Crawley JN, Duncan GE, Bodfish JW: Development of a mouse test for repetitive, restricted behaviors: Relevance to autism. Behav Brain Res 2008; 188: 178-194.
14. Duncan GE, Inada K, Farrington JS, Koller BH, Moy SS: Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress. Brain Res 2009; 1265: 186-195.
15. Ramsey AJ, Milenkovic M, Oliveira AF, Escobedo- Lozoya Y, Seshadri S, Salahpour A, Sawa A, Yasuda R, Caron MG: Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner. Proc Natl Acad Sci USA 2011; 108: 5795-5800.
16. Nakamura K, Koyama Y, Takahashi K, Tsurui H, Xiu Y, Ohtsuji M, Lin QS, Sugawara Y, Sawabe K, Ohashi A, Ohnuma T, Arai H, Nishimura H, Hasegawa H, Hirose S: Requirement of tryptophan hydroxylase during development for maturation of sensorimotor gating. J Mol Biol 2006; 363: 345-354.
17. Yun SW, Platholi J, Flaherty MS, Fu W, Kottmann AH, Toth M: Fmrp is required for the establishment of the startle response during the critical period of auditory development. Brain Res 2006; 1110: 159-165.
18. Bignami G, Alleva E, Chiarotti F, Laviola G: Selective changes in mouse behavioral development after prenatal benzodiazepine exposure: A progress report. Prog Neuropsychopharmacol Biol Psychiatry 1992; 16: 587-604.
19. Shnerson A, Willott JF: Ontogeny of the acoustic startle response in C57BL/6J mouse pups. J Comp Physiol Psychol 1980; 94: 36- 40.
20. Tremml P, Lipp HP, Muller U, Ricceri L, Wolfer DP: Neurobehavioral development, adult openfield exploration and swimming navigation learning in mice with a modified beta-amyloid precursor protein gene. Behav Brain Res 1998; 95: 65-76.
21. Ryan BC, Young NB, Crawley JN, Bodfish JW, Moy SS: Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain. Behav Brain Res 2010; 208: 178-188.
22. Duncan GE, Moy SS, Lieberman JA, Koller BH: Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav 2006; 85: 481-491.
23. Paylor R, Crawley JN: Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology (Berl) 1997; 132: 169-180.
24. Dulawa SC, Geyer MA: Psychopharmacology of prepulse inhibition in mice. Chin J Physiol 1996; 39: 139-146.
25. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN: Sociability and preference for social novelty in five inbred strains: An approach to assess autistic-like behavior in mice. Genes Brain Behav 2004; 3: 287-302.
26. Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, Barbaro JR, Wilson LM, Threadgill DW, Lauder JM, Magnuson TR, Crawley JN: Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains. Behav Brain Res 2007; 176: 4-20.
27. Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, Young NB, Barbaro RP, Piven J, Magnuson TR, Crawley JN: Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav 2004; 3: 303-314.
28. Duncan GE, Moy SS, Lieberman JA, Koller BH: Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl) 2006; 184: 190-200.
29. Fairless AH, Shah RY, Guthrie AJ, Li H, Brodkin ES: Deconstructing sociability, an autism-relevant phenotype, in mouse models. Anat Rec (Hoboken) 2011; 294: 1713- 1725.
30. Huggenberger HJ, Suter SE, Blumenthal TD, Schachinger H: Pre- and perinatal predictors of startle eye blink reaction and prepulse inhibition in healthy neonates. Psychophysiology 2011; 48: 1004-1010.
31. Anday EK, Cohen ME, Kelley NE, Hoffman HS: Reflex modification audiometry: Assessment of acoustic sensory processing in the term neonate. Pediatr Res 1988; 23: 357-363.
32. Ornitz EM, Guthrie D, Sadeghpour M, Sugiyama T: Maturation of prestimulation-induced startle modulation in girls. Psychophysiology 1991; 28: 11-20.
33. Hoffman HS, Cohen ME, English LM: Reflex modification by acoustic signals in newborn infants and in adults. J Exp Child Psychol 1985; 39: 562-579.
34. Castle D, Sham P, Murray R: Differences in distribution of ages of onset in males and females with schizophrenia. Schizophr Res 1998; 33: 179-183.
35. Leung A, Chue P: Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000; 401: 3-38.
36. Abel KM, Drake R, Goldstein JM: Sex differences in schizophrenia. Int Rev Psychiatry 2010; 22: 417-428.
37. Labrie V, Lipina T, Roder JC: Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology (Berl) 2008; 200: 217-230.
38. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE: Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 2006; 12: 824-828.
39. Moy SS, Troy Ghashghaei H, Nonneman RJ, Weimer JM, Yokota Y, Lee D, Lai C, Threadgill DW, Anton ES: Deficient NRG1-ERBB signaling alters social approach: Relevance to genetic mouse models of schizophrenia. J Neurodev Disord 2009; 1: 302-312.
40. Feyder M, Karlsson RM, Mathur P, Lyman M, Bock R, Momenan R, Munasinghe J, Scattoni ML, Ihne J, Camp M, Graybeal C, Strathdee D, Begg A, Alvarez VA, Kirsch P, Rietschel M, Cichon S, Walter H, Meyer-Lindenberg A, Grant SG, Holmes A: Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am J Psychiatry 2010; 167: 1508-1517.
41. Schaevitz LR, Moriuchi JM, Nag N, Mellot TJ, Berger-Sweeney J: Cognitive and social functions and growth factors in a mouse model of Rett syndrome. Physiol Behav 2010; 100: 255-263.
42. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY: Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010; 468: 263-269.
43. Blue ME, Kaufmann WE, Bressler J, Eyring C, O'Driscoll C, Naidu S, Johnston MV: Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice. Anat Rec (Hoboken) 2011; 294: 1624-1634.
44. Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, Li Y, Quinlan EM, Nakazawa K: Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 2010; 13: 76-83.
45. Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K, Uchiyama M, Sakuraba Y, Kaneda H, Shiroishi T, Houslay MD, Henkelman RM, Sled JG, Gondo Y, Porteous DJ, Roder JC: Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007; 54: 387-402.
46. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andrade M, Tankou S, Mori S, Gallagher M, Ishizuka K, Pletnikov M, Kida S, Sawa A: Dominantnegative DISC1 transgenic mice display schizophrenia- associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci USA 2007; 104: 14501- 14506.
47. Pletnikov MV, Ayhan Y, Nikolskaia O, Xu Y, Ovanesov MV, Huang H, Mori S, Moran TH, Ross CA: Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 2008; 13: 173- 186, 115.
48. Spear LP: The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000; 24: 417-463.
49. Hayashi-Takagi A, Barker PB, Sawa A: Readdressing synaptic pruning theory for schizophrenia: Combination of brain imaging and cell biology. Commun Integr Biol 2011; 4: 211-212.
50. Faludi G, Mirnics K: Synaptic changes in the brain of subjects with schizophrenia. Int J Dev Neurosci 2011; 29: 305-309.
51. Hoffman RE, Dobscha SK: Cortical pruning and the development of schizophrenia: A computer model. Schizophr Bull 1989; 15: 477-490.
52. Mirnics K, Middleton FA, Lewis DA, Levitt P: Analysis of complex brain disorders with gene expression microarrays: Schizophrenia as a disease of the synapse. Trends Neurosci 2001; 24: 479-486.
53. Alvarez VA, Ridenour DA, Sabatini BL: Distinct structural and ionotropic roles of NMDA receptors in controlling spine and synapse stability. J Neurosci 2007; 27: 7365- 7376.
54. Hayashi-Takagi A, Takaki M, Graziane N, Seshadri S, Murdoch H, Dunlop AJ, Makino Y, Seshadri AJ, Ishizuka K, Srivastava DP, Xie Z, Baraban JM, Houslay MD, Tomoda T, Brandon NJ, Kamiya A, Yan Z, Penzes P, Sawa A: Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci 2010; 13: 327- 332.
55. Veenema AH, Bredewold R, Neumann ID: Opposite effects of maternal separation on intermale and maternal aggression inC57BL/6 mice: Link to hypothalamic vasopressin and oxytocin immunoreactivity. Psychoneuroendocrinology 2007; 32: 437- 450.
56. Romeo RD, Mueller A, Sisti HM, Ogawa S, McEwen BS, Brake WG: Anxiety and fear behaviors in adult male and female C57BL/6 mice are modulated by maternal separation. Horm Behav 2003; 43: 561-567.
57. Wang L, Jiao J, Dulawa SC: Infant maternal separation impairs adult cognitive performance in BALB/cJ mice. Psychopharmacology (Berl) 2011; 216: 207-218.
58. Binder E, Malki K, Paya-Cano JL, Fernandes C, Aitchison KJ, Mathe AA, Sluyter F, Schalkwyk LC: Antidepressants and the resilience to early-life stress in inbred mouse strains. Pharmacogenet Genomics 2011; 21: 779-789.
59. Mehta M, Schmauss C: Strain-specific cognitive deficits in adult mice exposed to early life stress. Behav Neurosci 2011; 125: 29-36.
60. Millstein RA, Holmes A: Effects of repeated maternal separation on anxiety- and depression- related phenotypes in different mouse strains. Neurosci Biobehav Rev 2007; 31: 3- 17.
61. Millstein RA, Ralph RJ, Yang RJ, Holmes A: Effects of repeated maternal separation on prepulse inhibition of startle across inbred mouse strains. Genes Brain Behav 2006; 5: 346-354.
62. Thompson JL, Pogue-Geile MF, Grace AA: Developmental pathology, dopamine, and stress: A model for the age of onset of schizophrenia symptoms. Schizophr Bull 2004; 30: 875-900.
63. Walker E, Mittal V, Tessner K: Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 2008; 4: 189-216.
64. Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-669.
65. Lieberman JA: Neuroprotection: A new strategy in the treatment of schizophrenia. Neurobiological basis of neurodegeneration and neuroprotection. CNS Spectr 2007; 12(10 suppl 18):4-6.
66. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M: Antipsychotic drug effects on brain morphology in firstepisode psychosis. Arch Gen Psychiatry 2005; 62: 361-370.
67. Salimi K, Jarskog LF, Lieberman JA: Antipsychotic drugs for first-episode schizophrenia: A comparative review. CNS Drugs 2009; 23: 837-855.
68. Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG: Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev 2008; 60: 358-403.
69. Done DJ, Crow TJ, Johnstone EC, Sacker A: Childhood antecedents of schizophrenia and affective illness: Social adjustment at ages 7 and 11. BMJ 1994; 309: 699-703.
70. Welham J, Isohanni M, Jones P, McGrath J: The antecedents of schizophrenia: A review of birth cohort studies. Schizophr Bull 2009; 35: 603-623.
71. Larson MK, Walker EF, Compton MT: Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother 2010; 10: 1347-1359.